What does cygnus — asset impairments mean?

Reflects non-cash charges recognized when the carrying value of long-lived assets within the Biologics Safety Testing segment exceeds their recoverable amount. This metric indicates potential declines in the value of equipment, technology, or intangible assets. It serves as a critical indicator of asset health and potential future operational challenges.

Maravai LifeSciences Holdings, Inc. MRVI Cygnus — Asset Impairments

Other segment segments

TriLink

$605K-77.6%

Corporate

$0-100%

Similar metrics at other companies

IMAXAsset impairments

$0—

GPIAsset impairments

$2.5M+525%

GPIU.S. — Asset impairments

$1.9M+183%

YOUImpairment of assets

$90.5K-49.9%

LYBImpairments

$126.75M—

LYBOther — Impairments

$0—

Other financials

Income statement

See full

Revenue$65.8M+40.5%

Gross profit$33.7M+336%

Operating income-$2.2M+95.6%

Net income-$3.7M+87.5%

EPS (diluted)-$0.02+90.5%

Balance sheet

See full

Cash & equivalents$165.9M-41.8%

Total debt$270.9M-17.1%

Total equity$211.6M-29.6%

Total assets$713.2M-25.7%

Cash flow

See full

Operating cash flow$8.7M+192%

CapEx$4.4M-1.4%

Free cash flow$4.2M+130%

Valuation

See full

Market cap$849.64M+186%

Enterprise value$954.59M+182%

P/S4.2×+2.9×

Profitability

See full

Gross margin29.3%-8.0pp

Operating margin-82.2%-16.6pp

Net margin-51.1%-9.9pp

FCF margin-25.7%—

Returns & leverage

See full

Return on equity-40.8%-4.0pp

Debt / equity1.3×+0.2×

Current ratio5.9×-0.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ImpairmentOfLongLivedAssetsHeldForUse.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s cygnus — asset impairments.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s cygnus — asset impairments?: Maravai LifeSciences Holdings, Inc. (MRVI) reported cygnus — asset impairments of $0 in Q1 2026.
What does cygnus — asset impairments mean?: Reflects non-cash charges recognized when the carrying value of long-lived assets within the Biologics Safety Testing segment exceeds their recoverable amount. This metric indicates potential declines in the value of equipment, technology, or intangible assets. It serves as a critical indicator of asset health and potential future operational challenges.